Blood Transfusion Vs. Hydroxyurea for Stroke Prevention in Children With Sickle Cell Anemia: A Systematic Review and Meta-Analysis

Sickle cell anemia (SCA) is a hereditary condition that can lead to severe complications in children such as acute coronary syndrome, splenic sequestration, renal failure, and stroke. Blood transfusion and hydroxyurea (HU) therapy are used to prevent stroke in children with sickle cell disease (SCD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafiz, Tamara A, Aldharman, Sarah S, AlSubaie, Ruby N, Alzahrani, Lena D, Albalawi, Ibrahim Ahmed J, Alali, Yara A, Yousuf, Maisaa M, Alharbi, Hayat M, Alamri, Nawaf S, Jamil, Syed F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774052/
https://www.ncbi.nlm.nih.gov/pubmed/36569706
http://dx.doi.org/10.7759/cureus.31778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774052/
https://www.ncbi.nlm.nih.gov/pubmed/36569706
http://dx.doi.org/10.7759/cureus.31778

Ejemplares similares